Murcko scaffold
Ring system with 2 rings and 26 atoms
22 chemicals on CompoundList share this ring system.
- Rings
- 2
- Scaffold atoms
- 26
- Chemicals
- 22
- With full pages
- 2
Scaffold SMILES
O=C1C=CC=CCCCCC=CC=CCC(CCCC2CCCCO2)O1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 22 of 22 chemicals
Bafilomycin A
CAS 116764-51-3C35H58O9
Bafilomycin A1
CAS 88899-55-2C35H58O9
Bafilomycin C1
CAS 88979-61-7C39H60O12
Bafilomycin A2
CAS 88899-54-1C36H60O9
Bafilomycin C2
CAS 82623-58-3C40H62O12
Bafilomycin C1 amide
CAS 695189-31-2C39H61NO11
Hygrolidin amide
CAS 90965-59-6C38H59NO10
(E)-4-[2-Hydroxy-2-[3-hydroxy-4-[(4Z,6E,12E,14E)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-5,6-dimethyloxan-4-yl]oxy-4-oxobut-2-enoic acid
CAS 142386-67-2C37H56O12
(E)-4-[2-[3-Hydroxy-4-[(4Z,6E,12E,14E)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-2-methoxy-5,6-dimethyloxan-4-yl]oxy-4-oxobut-2-enoic acid
CAS 142386-69-4C38H58O12
TS 155-2
CAS 303009-07-6C39H60O11
TS 155-2
C39H60O11
4-[2-Hydroxy-2-[3-hydroxy-4-(10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl)pentan-2-yl]-5-methyl-6-propan-2-yloxan-4-yl]oxy-4-oxobutanoic acid
CAS 849808-12-4C39H62O12
TS 155-2
CAS 1314486-37-7C39H60O11
Defumarylhygrolidin
CAS 90965-58-5C34H56O7
Antibiotic 1166C
C38H58O11
Orb1692183
CAS 83329-73-1C38H58O11
(E)-4-[(2R,4R,5S,6R)-6-Ethyl-2-hydroxy-2-[(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4Z,6Z,9S,10S,11R,12Z,14Z)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-5-methyloxan-4-yl]oxy-4-oxobut-2-enoic acid
C38H58O11
TS 155-2
C39H60O11
(2E)-4-{[(2R,4R,5S,6R)-6-Ethyl-2-hydroxy-2-[(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4E,6E,9S,10S,11R,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-5-methyloxan-4-yl]oxy}-4-oxobut-2-enoic acid
C38H58O11
(E)-4-[(2R,4R,5S,6R)-6-Ethyl-2-hydroxy-2-[(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl]-5-methyloxan-4-yl]oxy-4-oxobut-2-enoic acid
C38H58O11
4-[(2R)-6-Ethyl-2-hydroxy-2-[3-hydroxy-4-(10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl)pentan-2-yl]-5-methyloxan-4-yl]oxy-4-oxobut-2-enoic acid
C38H58O11
2-Butenedioic acid (2E)-, mono[(2R,4R,5S,6R)-6-ethyltetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-2H-pyran-4-yl] ester
C38H58O11